4//SEC Filing
Aroesty Jason D 4
Accession 0001038133-18-000045
CIK 0001038133other
Filed
Jul 26, 8:00 PM ET
Accepted
Jul 27, 1:44 PM ET
Size
9.8 KB
Accession
0001038133-18-000045
Insider Transaction Report
Form 4
HESKA CORPHSKA
Aroesty Jason D
EVP, International Diagnostics
Transactions
- Award
Incentive Stock Option (right to buy)
2018-07-25+2,811→ 2,811 totalExercise: $106.67Exp: 2028-07-24→ Common Stock (2,811 underlying) - Award
Performance Shares
2018-07-25+4,688→ 4,688 totalExp: 2025-03-31→ Common Stock (4,688 underlying) - Award
Non-Qualified Stock Option (right to buy)
2018-07-25+17,189→ 17,189 totalExercise: $106.67Exp: 2028-07-24→ Common Stock (17,189 underlying)
Footnotes (2)
- [F1]The aggregate of these two option awards vests in three approximately equal annual installments beginning on July 25, 2019 and ending on July 25, 2021.
- [F2]The vesting of each of three approximately equal performance share tranches is contingent on the achievement of certain market-vesting thresholds based on the price per share of Heska's common stock average over a 20-day trailing trading period. The first tranche is to vest at the achievement of $133.34 per share and the second anniversary of grant date. The second tranche is to vest at the achievement of $154.67 per share and the third anniversary of grant date. The third tranche is to vest at the achievement of $186.67 per share and the fourth anniversary of grant date. Any performance shares that do not vest by March 31, 2025 are to be forfeited.
Documents
Issuer
HESKA CORP
CIK 0001038133
Entity typeother
Related Parties
1- filerCIK 0001737532
Filing Metadata
- Form type
- 4
- Filed
- Jul 26, 8:00 PM ET
- Accepted
- Jul 27, 1:44 PM ET
- Size
- 9.8 KB